Log in

Tivity Health (NASDAQ:TVTY) Downgraded by BidaskClub to Buy

Wednesday, September 16, 2020 | MarketBeat

Tivity Health (NASDAQ:TVTY) was downgraded by stock analysts at BidaskClub from a "strong-buy" rating to a "buy" rating in a report issued on Wednesday, BidAskClub reports.

A number of other brokerages have also commented on TVTY. Zacks Investment Research upgraded shares of Tivity Health from a "sell" rating to a "strong-buy" rating and set a $19.00 price target on the stock in a research note on Thursday, August 13th. Barrington Research upped their price target on shares of Tivity Health from $15.00 to $27.00 and gave the company an "outperform" rating in a research note on Thursday, August 6th. Craig Hallum upgraded shares of Tivity Health from a "hold" rating to a "buy" rating and upped their price target for the company from $10.00 to $20.00 in a research note on Thursday, August 6th. SunTrust Banks upped their price target on shares of Tivity Health from $10.00 to $11.00 and gave the company a "hold" rating in a research note on Thursday, May 21st. Finally, Guggenheim started coverage on shares of Tivity Health in a research note on Friday, June 12th. They issued a "neutral" rating on the stock. One analyst has rated the stock with a sell rating, seven have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. Tivity Health has a consensus rating of "Hold" and a consensus target price of $18.67.

Shares of TVTY stock opened at $14.19 on Wednesday. The company has a debt-to-equity ratio of 26.60, a quick ratio of 0.81 and a current ratio of 0.96. The firm's 50-day moving average is $15.77 and its 200-day moving average is $10.87. The stock has a market cap of $689.07 million, a price-to-earnings ratio of -1.43, a PEG ratio of 1.02 and a beta of 2.32. Tivity Health has a 52-week low of $1.92 and a 52-week high of $26.07.

Tivity Health (NASDAQ:TVTY) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.79 EPS for the quarter, beating the Zacks' consensus estimate of $0.25 by $0.54. Tivity Health had a negative net margin of 40.68% and a positive return on equity of 36.30%. Sell-side analysts predict that Tivity Health will post 1.42 EPS for the current fiscal year.

Institutional investors have recently modified their holdings of the company. Balyasny Asset Management LLC bought a new stake in shares of Tivity Health during the 1st quarter worth approximately $111,000. Geode Capital Management LLC lifted its holdings in shares of Tivity Health by 9.2% during the 1st quarter. Geode Capital Management LLC now owns 665,214 shares of the company's stock worth $4,184,000 after acquiring an additional 56,202 shares during the period. Invesco Ltd. lifted its stake in Tivity Health by 5.8% in the 1st quarter. Invesco Ltd. now owns 347,892 shares of the company's stock valued at $2,189,000 after purchasing an additional 18,985 shares during the last quarter. State Street Corp lifted its stake in Tivity Health by 13.3% in the 1st quarter. State Street Corp now owns 1,809,624 shares of the company's stock valued at $11,383,000 after purchasing an additional 212,532 shares during the last quarter. Finally, Two Sigma Advisers LP lifted its stake in Tivity Health by 485.2% in the 1st quarter. Two Sigma Advisers LP now owns 331,124 shares of the company's stock valued at $2,083,000 after purchasing an additional 274,543 shares during the last quarter. 99.21% of the stock is owned by institutional investors.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

See Also: How Do I Invest in Dividend Stocks

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

7 Gold Stocks to Buy Before the Fed Changes Its Mind

Just when investors thought that the price of gold couldn’t go any higher, the Federal Reserve added fuel to the fire. On July 29, the Fed said there was not sufficient evidence of an economic recovery to warrant changing their current policies. Not only does that mean that interest rates will stay at or nor zero, but that the Fed may initiate other actions as well. In his statement after the Fed meeting, chairman Jerome Powell said the Fed was “not even thinking about thinking about raising rates.” And while the novel coronavirus was certainly a factor, it’s not the only factor. The Fed is looking intently at the collateral damage from the lockdown measures in March and April. Over 14 million Americans who had jobs in February are unemployed. And many of those jobs will not be coming back.

This is creating the perfect scenario for gold and gold stocks. The price of gold has surged over 25% in 2020. At the time of this writing, it sits at $1,953 per ounce. Of course as soon as gold starts to near $2,000 the cries that the rally is over begin.

Are they right again? Maybe, but I’m a little skeptical. Gold always climbs during times of uncertainty. That’s true today more than ever. We’re months away from a presidential election. We’re learning how to live with a novel virus for which there is no vaccine. We have social unrest that has turned into riots in many major cities.

With that in mind, here are seven of the best gold stocks that you can invest in right now.

View the "7 Gold Stocks to Buy Before the Fed Changes Its Mind".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.